Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Short-term Investments (2016 - 2025)

Fresenius Medical Care AG has reported Short-term Investments over the past 16 years, most recently at $519.8 million for Q4 2025.

  • Quarterly results put Short-term Investments at $519.8 million for Q4 2025, up 12.14% from a year ago — trailing twelve months through Dec 2025 was $519.8 million (up 12.14% YoY), and the annual figure for FY2025 was $519.8 million, up 12.14%.
  • Short-term Investments for Q4 2025 was $519.8 million at Fresenius Medical Care AG, up from $463.5 million in the prior quarter.
  • Over the last five years, Short-term Investments for FMCQF hit a ceiling of $519.8 million in Q4 2025 and a floor of $3.9 million in Q4 2021.
  • Median Short-term Investments over the past 5 years was $262.7 million (2023), compared with a mean of $300.6 million.
  • Biggest five-year swings in Short-term Investments: tumbled 49.33% in 2021 and later soared 6369.98% in 2022.
  • Fresenius Medical Care AG's Short-term Investments stood at $3.9 million in 2021, then soared by 6369.98% to $252.9 million in 2022, then rose by 3.88% to $262.7 million in 2023, then skyrocketed by 76.42% to $463.5 million in 2024, then grew by 12.14% to $519.8 million in 2025.
  • The last three reported values for Short-term Investments were $519.8 million (Q4 2025), $463.5 million (Q4 2024), and $262.7 million (Q4 2023) per Business Quant data.